Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations

PURPOSE: During the coronavirus disease 2019 (COVID-19) pandemic, the European Association of Urology (EAU) recommended that courses of intravesical bacillus Calmette-Guérin (BCG) therapy lasting more than 1 year could be safely terminated for patients with high-risk non-muscle-invasive bladder canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Young Joon, Cho, Kang Su, Jeong, Jae Yong, Chung, Doo Yong, Kang, Dong Hyuk, Jung, Hae Do, Lee, Joo Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455878/
https://www.ncbi.nlm.nih.gov/pubmed/36074771
http://dx.doi.org/10.1371/journal.pone.0273733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455878/
https://www.ncbi.nlm.nih.gov/pubmed/36074771
http://dx.doi.org/10.1371/journal.pone.0273733

Ejemplares similares